AnGes MG, Avontec Enter into Cross Licensing Agreement for Decoy Nucleic Acid Drug.Tokyo, Japan, Aug 11, 2005 - (JCNN JCNN Japan Corporate News Network ) - AnGes MG announced on August 10 that it has signed a cross licensing agreement with German bio-venture company Avontec on the development of decoy DECOY. A pond used for the breeding and maintenance of water-fowl. 11 Mod. 74, 130; S. C. 3 Salk. 9; Holt, 14 11 East, 571. nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. drugs. Under the terms of the agreement, AnGes MG will be able to exclusively use Avontec's proprietary technology STAT-1 decoy oligodeoxynucleotides in Asia to develop applications for respiratory and respiratory and skin diseases. Meanwhile, Avontec will be granted the right to use NF-kappa B decoy oligodeoxynucleotide (NFkB decoy oligo), a kind of nucleic acid medicine developed by AnGes MG, in Europe with a view to applying it to the treatment of psoriasis psoriasis (sôrī`əsĭs), occasionally acute but usually chronic and recurrent inflammation of the skin. The exact cause is unknown, but the disease appears to be an inherited, possibly autoimmune disorder that causes the . Avontec, which was launched by the Georg-August-University Goettingen in Germany in 2001, specializes in research and development of nucleic acid-based drugs. Through the partnership, the two companies aim to improve their development capabilities by sharing their expertise. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion